Next Article in Journal
Evidence of Insulin-Sensitizing and Mimetic Activity of the Sesquiterpene Quinone Avarone, a Protein Tyrosine Phosphatase 1B and Aldose Reductase Dual Targeting Agent from the Marine Sponge Dysidea avara
Next Article in Special Issue
Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
Previous Article in Journal
Rapidly Dissolving Microneedles for the Delivery of Steroid-Loaded Nanoparticles Intended for the Treatment of Inflammatory Skin Diseases
Previous Article in Special Issue
Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 15
Issue 2
10.3390/pharmaceutics15020529
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

One-Step Phytofabrication Method of Silver and Gold Nanoparticles Using Haloxylon salicornicum for Anticancer, Antimicrobial, and Antioxidant Activities

by
Reham Samir Hamida
1,
Mohamed Abdelaal Ali
2,
Haifa Essa Alfassam
3,
Maha Abdullah Momenah
3,
Mariam Abdulaziz Alkhateeb
3,* and
Mashael Mohammed Bin-Meferij
3,4
1
Laboratory for Nanobiology, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan
2
Plant Production Department, Arid Lands Cultivation Research Institute, City of Scientific Research and Technological Applications (SRTA-CITY) New Borg El-Arab, Alexandria 21934, Egypt
3
Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia
4
Histopathology Unit, Research Department, Health Sciences Research Center (HSRC), Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia
*
Author to whom correspondence should be addressed.
Pharmaceutics 2023, 15(2), 529; https://doi.org/10.3390/pharmaceutics15020529
Submission received: 4 January 2023 / Revised: 31 January 2023 / Accepted: 2 February 2023 / Published: 4 February 2023
(This article belongs to the Special Issue Novel Metal-Based Drugs for Anticancer and Antiviral Applications)
Browse Figures
Versions Notes

Abstract

:
Among various routes of metallic nanoparticle (NPs) fabrication, phytosynthesis has significant advantages over other conventional approaches. Plant-mediated synthesis of NPs is a fast, one-step, ecobenign, and inexpensive method with high scalability. Herein, silver (Ag) and gold (Au)-NPs were extracellularly synthesized using aqueous Haloxylon salicornicum (H@Ag-, H@Au-NPs) leaf extracts. GC-MS was performed to analyze the chemical compositions of H. salicornicum extract. H@Ag- and H@Au-NPs were characterized via UV-Vis spectroscopy, Fourier transform infrared spectroscopy, X-ray diffraction, transmission and scanning electron microscopy, and Zetasizer. H@Ag- and H@Au-NPs have surface plasmon resonance at 435.5 and 530.3 nm, respectively. FTIR and GC-MS data suggest that secondary plant metabolites and hydrocarbons might be responsible for the reduction and stabilization of NPs. XRD demonstrated that both NPs have a crystalline nature. H@Ag-NPs have a uniform spherical shape, whereas H@Au-NPs are spherical with few oval and triangular shapes, and their average nanosizes were 19.1 ± 0.8 and 8.1 ± 0.3 nm, respectively. Hydrodynamic diameters of H@Ag-NPs and H@Au-NPs were 184.7 nm, 56.4, and 295.4 nm, and their potential charges were −24.0 and −24.4 mV, respectively. The inhibitory activity of 500 µg/mL H@Ag- and H@Au-NPs was tested against Sw480, Sw620, HCT-116, and Caco-2 colon cancer cell lines and two normal cell lines, including HFs and Vero. H@Ag-NPs revealed potent anticancer activity against all cancer cells at low concentrations. Sw480 was the most sensitive cell to H@Ag-NPs, whereas Sw620 was the least permeable one. These findings suggested that the antiproliferative activity of H@Ag-NPs is cell-response-dependent and may be influenced by a variety of factors, including the cellular metabolic state, which influences cellular charge and interactions with charged NPs. Although H@Au-NPs were smaller, their reactivity against cancer cells was weak, suggesting that the chemical properties, metal structure, quantity and chemistry of the functional groups on the NP surface may influence their reactivity. The biocidal activity of 1 mg/mL H@Ag- and H@Au-NPs against Staphylococcus aureus, Bacillus cereus, Escherichia coli and Klebsiella pneumoniae was assessed. H@Ag-NPs showed biocidal activity against Gram-positive bacteria compared to Gram-negative bacteria, whereas H@Au-NPs showed no inhibitory activity. FRAP and DPPH assays were used to determine the scavenging activity of the plant extracts and both NPs. H@Ag-NPs (1 mg/mL) had the greatest scavenging activity compared to tested drugs. These findings suggest that H@Ag-NPs are potent anticancer, antibacterial, and antioxidant agents, while H@Au-NPs may be used as a drug vehicle for pharmaceutical applications.

Graphical Abstract

1. Introduction

Phyto-mediated synthesis is an emerging cutting-edge nanobiotechnology due to its fast, renewable, and eco-benign synthesis method with low-cost consumption and hazard yields compared to conventional methods [1,2]. Phytosynthesis depends on the potential of plants to uptake, accumulate, utilize, and recycle different mineral species [3,4]. Generally, in an ecosystem, biological systems such as bacteria, diatoms, plants, etc., produce a variety of superstructure inorganic nanomaterials, such as magnetite, amorphous silica, and calcite, to reduce their toxicity via detoxification or remediation processes [5,6,7]. These biological systems contain a vast number of biomolecules, such as proteins, enzymes, pigments, essential oils, fatty acids, and hydrocarbons, and metabolites, such as terpenoids, flavonoids, and others, which work as reductants and capping agents for reducing and stabilizing nanoparticles (NPs) [8,9,10,11]. Due to the necessity to produce large-scale yields of biocompatible NPs with low toxicity to living systems in short time periods, plants are considered the most attractive neutral source for NP synthesis [1]. The use of plants for NP synthesis has many advantages, including availability, safety, high biomass production, and a wide range of primary and secondary metabolites that reduce precursor metals into their NP form in a few minutes or hours [10,12]. Inorganic NPs have acquired significance in various applied sectors, such as in medical, pharmaceutical, industrial, electronic, etc., applications. These NPs are used as therapeutic agents [13], biosensors [14], bioimaging [15], drug carriers [16], and electroactive cells [17]. The wide range of inorganic NP uses arises from their distinct physicochemical and biological characteristics, including their small size to the large surface area, high surface energy, a large fraction of surface atoms, reduced imperfections, spatial confinement, surface plasmon light scattering, surface plasmon resonance (SPR), surface-enhanced Rayleigh scattering, surface-enhanced Raman, and scattering (SERS) properties [18,19]. Many reports have shown the ability of several plant parts, including the leaves, roots, stems [20], seeds [21], flowers [22], and others, to synthesize various controlled shapes and sizes of inorganic NPs that incorporate silver [20], gold [20], platinum [23], palladium [24], and metal oxides such as titanium oxide [25], iron oxide [26], copper oxide [27], etc. These green NPs exhibit potent biological activity against pathogenic bacteria, such as Streptococcus pneumoniae causing meningitis [28], Klebsiella pneumoniae causing pneumonia and bloodstream infections [29], Escherichia coli causing urinary tract infections [30], and Staphylococcus aureus causing infective endocarditis and osteoarticular infections [31]. Moreover, biogenic NPs show great antiproliferative activities against cancers, such as breast, cervical, brain, leukemia, colon, etc., at experimental levels [32]. On the other hand, plant-mediated NPs have anti-inflammatory [33], antidiabetic [34], antiparasitic [35], antioxidant [36], and catalytic activities [37]. General NPs enhance apoptotic pathways inside malignant cells via crosstalk between several events, including enhancing ROS formation causing oxidative stress, impacting protein expression, DNA damage, immunological interventions, inhibition of transcription, site-specific cytotoxicity, and others [38]. Similarly, the main mechanism of NP action against bacterial cells is due to their potential to induce oxidative stress and interact with cellular barriers to alter membrane permeability and integrity and impact the functions of cellular components, including DNA, proteins, and enzymes, to cause dysfunction and bacterial cell death [39]. The current study reports for the first time a one-step synthesis method using Haloxylon salicornicum aqueous extract to create silver and gold NPs while emphasizing their anticancer, antibacterial, and antioxidant activities.

2. Materials and Methods

2.1. Materials

Silver nitrate (AgNO3), MTT, Resazurin dye, FRAP and DPPH kits, DMSO, and microbial materials such as nutrient agar were purchased from Sigma-Aldrich, St. Louis, MO, USA. Chloroauric acid (HAuCl4.3H2O) was purchased from Loba Chemie. Cell culture media, trypsin, penicillin/streptomycin, and phosphate buffer saline were purchased from Gibco, Waltham, MA, USA.

2.2. Methods

2.2.1. Preparation of Plant Extracts

H. salicornicum leaves were collected from the Experimental Research Station, Faculty of Food and Agriculture Sciences, King Saud University, Dirab, 35 km southwest of Riyadh, Saudi Arabia (24°39′ N, 46°44′ E) and washed three times with distilled (dist.) water to remove any undesired matter and dried in an oven at 50 °C for three days. Dried leaves were crushed into a fine powder using a Waring grinder machine (Waring 7011SC Blender, Waring, Stamford, CT, USA) and kept in sterilized containers for further applications. Plant powder (2 g) was mixed with 100 mL of dist. H2O and boiled at 80 °C in a water bath for 15 min. After heating, the mixture was allowed to be cool and was filtered using Whatman filter paper No. 1, size 185 mm. The filtrate was centrifuged at 4700 rpm for 10 min to eliminate any plant debris [40].

2.2.2. Gas Chromatography-Mass Spectroscopy

The H. salicornicum extract was prepared by mixing 2 g dried powder with 100 mL boiled dist. H2O (80 °C) and sonicating for 30 min. The specimen was allowed to macerate for 24 h and centrifuged at 4700 rpm for 10 min. The supernatant was filtered using a syringe filter (0.22 µm), and the filtrate was dried under a vacuum at 50 °C for 48 h. A Trace GC-TSQ mass spectrometer (Thermo Scientific, Austin, TX, USA) with a direct capillary column TG–5MS (30 m × 0.25 mm × 0.25 µm film thickness) was used to identify the phytometabolites in the H. salicornicum extract under the same conditions and methods mentioned in our previous published paper [41]. Plant biomolecules were detected by comparison of their mass spectra with those of WILEY 09 and NIST 14 mass spectral databases.

2.2.3. Silver and Gold Nanoparticle Synthesis Using Aqueous Plant Extracts

To fabricate H@Ag-NPs, 1 mL of aqueous plant extract was mixed with 9 mL of 1 mM AgNO3 and kept under a light (2000 ± 200 lux) for 24 h at ambient temperature. In this step, the color of the mixture converted from golden yellow to reddish brown after 24 h. H@Au-NPs were synthesized by mixing 1 mL of plant extract with 9 mL of 1 mM of HAuCl4.3H2O and kept at 80 °C in a water bath for 30 min until the reddish pink color became stable. Afterward, the H@Au-NPs suspension was kept at ambient temperature in the dark for 24 h. After 24 h, H@Ag-NP and H@Au-NP suspensions were centrifuged at 12,000 rpm for 15 min and washed at least three times with dist. H2O to remove any undesired plant matrix. Both H@Ag-NP and H@Au-NP pellets were collected and freeze-dried using a lyophilizer (LYOTRAP, LTE Scientific, Greenfield, UK) for 12 h [42,43].

2.2.4. Physicochemical Characterization of Silver and Gold Nanoparticles

UV-Vis Spectroscopy

To detect the wavelengths of H@Ag-NPs and H@Au-NPs, an aliquot (2 mL) was drawn from the H@Ag-NP and H@Au-NP suspensions after 24 h and measured using UV-spectroscopy (Model UV-1800, Shimadzu, Kyoto, Japan) at a wavelength range of 200–800 nm with 1 nm resolution.

X-ray Diffraction Analysis

The crystalline structures of H@Ag-NPs and H@Au-NPs were detected using an X-ray diffractometer, D8 Advance (Bruker, Bremen, Germany). The dried H@Ag-NP and H@Au-NP powders were coated on XRD grids and estimated over 0° to 80° (2θ) using Cu K α radiation generated at 30 kV and 30 mA with a scan speed 4 deg/min.

Fourier-Transform Infrared Spectroscopy

The functional groups of biomolecules surrounding H@Ag-NP and H@Au-NP surfaces that existed in the H. salicornicum extract were estimated using FTIR (Shimadzu, Kyoto, Japan). H@Ag-NP and H@Au-NP suspensions were centrifuged at 12,000 rpm for 15 min, washed at least three times, and lyophilized. The powdered H@Ag-NPs, H@Au-NPs, and plant extract were examined within a spectra range of 400 to 4000 cm−1 at a resolution of 4 cm−1.

Transmission Electron Microscope

TEM was used to determine the shape and size of H@Ag-NPs and H@Au-NPs. After washing H@Ag-NPs and H@Au-NPs at least three times with dist. H2O, the pellets were washed three times with 70% ethanol, and 200 µL of each NP suspension was kept in 1 mL of ethanol and sonicated for 15 min. Then, 20 µL of each NP suspension was loaded onto carbon-coated copper grids and allowed to dry at room temperature. The samples were examined using TEM (JEM-1400Flash, Jeol, Akishima, Japan) at 120 kV. The frequency distribution of H@Ag-NPs and H@Au-NPs was determined by measuring the diameter of approximately 100 NPs using ImageJ [41].

Scanning Electron Microscope, Energy-Dispersive X-ray, and Mapping Analysis

SEM was used to demonstrate the morphological appearance of H@Ag-NPs and H@Au-NPs. An amount of 20 µL of the sonicated NP suspensions was spread onto cleaned glass slides and allowed to dry at room temperature. Dried slides were then coated with platinum using a sputter coater (JEC-3000FC, Jeol, Japan) at 1.8 pa and 10 mA for 80 s, and the glass piece was pasted to a copper stub using carbon paste tape and examined at 15 kV. A JSM-IT500HR EDX detector (STD-PC80, Jeol, Japan) was used to demonstrate the elemental compositions and elemental distribution maps of H@Ag-NPs and H@Au-NPs. NP powders were placed on clean clink paper and transferred to carbon paste strips attached to copper stubs and smoothly knocked to remove any excess powder and coated by platinum [41].

Dynamic Light Scattering and Zeta Potential Analysis

The hydrodynamic diameter, particle distribution, and potential charge of H@Ag-NP and H@Au-NP suspensions were detected using Zetasizer equipment (Malvern, UK). In brief, H@Ag-NP and H@Au-NP suspensions were diluted ten-fold using dist. H2O and then sonicated for 15 min and transferred into Zetasizer tubes at 25 °C for examination.

2.2.5. Antimicrobial Activity of Silver Nanoparticles

Agar Well Diffusion Method

The agar well diffusion method was performed to detect the biocidal activity of H. salicornicum, H@Ag-NPs, H@Au-NPs, and ciprofloxacin (as positive control) against four pathogenic bacteria, including two Gram-positive (Staphylococcus aureus ATCC 29213 and Bacillus cereus ATCC 9634), and two Gram-negative bacteria (Escherichia coli ATCC 25922 and Klebsiella pneumoniae ATCC13883). The tested bacteria were cultured in nutrient broth for up to 18 h at 37 °C and maintained through continuous subculturing in broth and on solid media. Bacterial isolate (4 mL of 2.5–3.6 × 106 CFU/mL) was mixed with 50 mL nutrient agar medium, poured into sterilized Petri dishes, and dried at 37 °C. Four 8 mm wells were created in the agar plates using a cork borer. After that, 100 µL of ciprofloxacin (5 µg/mL as a positive control), 25 mg/mL H. salicornicum extract, or 1 mg/mL of H@Ag-NPs and H@Au-NPs was added to each well. An amount of 100 µL dist. H2O served as a negative control. The plates were incubated for 24 h at 37 °C, and the inhibition zone of each treatment was measured using a transparent ruler [44].

Minimum Inhibition and Maximum Bactericidal Concentrations

A resazurin dye assay was performed to determine the minimum inhibition concentration at which 99% of cell growth was inhibited by the treatment and the minimum bactericidal concentration at which 100% of cell growth was inhibited. A total of 100 µL of two-fold serial dilutions of H. salicornicum, H@Ag-NPs, and H@Au-NPs (500, 250, 125, 62.5, 31.25, 15.62, 7.8, 3.9, 1.95, and 0.98 µg/mL) were added in triplicate across 96-well plates (from column 1 to 10). Next, 100 µL of the bacterial suspension (2.5–3.6 × 106 CFU/mL) was mixed into each well; column 11 represented the positive control (bacterial suspension without treatment), and column 12 represented the negative control (media only). The plates were kept in the incubator for 24 h at 37 °C. After incubation, 30 µL/well of resazurin dye solution (0.015 g resazurin in 100 mL dist. H2O) was added, and plates were incubated at 37 °C for 4 h. Absorbance was then measured using a plate reader at 570 nm. Columns with a resazurin blue color (unchanged) were considered to be above the MIC value. The MBC values were estimated by plating the contents of the wells with concentrations higher than the MIC value on nutrient agar plates [45].

2.2.6. Anticancer Activity of Silver Nanoparticles

Cell Culture

The selected cell lines (colon cancer cell lines; Sw480, Sw620, HCT-116, Caco-2, and normal cell lines; human fibroblast (HFs) and kidney cells of an African green monkey (Vero)) were cultured in complete RPMI and DMEM media containing 10% FBS and 50 U/mL penicillin and streptomycin antibiotics. The cells were kept in a 5% CO2 incubator at 37 °C. At 80% confluency, the cells were trypsinized using trypsin-EDTA and counted, and 5 × 104 cells/well seeded into 96-well plates and kept in a 5% CO2 incubator for 24 h at 37 °C [41].

MTT Assay

An MTT assay was used to detect the cytotoxicity of H@Ag-NPs, H@Au-NPs, and 5-FU (positive control) against the selected cells. Firstly, 500 µg of H@Ag-NPs and H@Au-NPs were weighed and dissolved in 1 mL of DMEM media and sonicated for 15 min until all particles became well dispersed in the media. After that, the suspension was filtrated using a microfilter with a pore size of 0.45 µm. Several concentrations of filtrated 5-FU, H@Ag-NPs, and H@Au-NPs (500, 250, 125, 62.5, 31.25, 15.62, 7.8, and 3.9 µg/mL) were prepared, and 100 µL of each concentration was added to cells in 96-well plates and incubated at 37 °C for 24 h. The media of treated plates were discarded, and 100 µL/well of fresh media was added to each well. Then 10 µL/well of MTT solution (5 mg/mL) was mixed with media and kept in the dark at 37 °C for 4 h. After incubation, 100 µL of absolute DMSO was added to each well to dissolve the formazan crystals and kept on a shaker plate (120 rpm) for 15 min. The absorbance was detected using an ELISA plate reader (Bio-Rad, Hercules, CA, USA) at 570 nm [46]. The cell viability (%) was estimated according to the following equation
Abs(treated) − Abs(blank)/(Abs(control) − Abs(blank)) × 100
The IC50 (half-maximal growth inhibitory concentration) was calculated using a sigmoidal curve.

2.2.7. Antioxidant Activity of Nanoparticles

DPPH Assay

The scavenging activity of plant extracts, H@Ag-NPs, and H@Au-NPs was assessed using a DPPH assay. In brief, 1 mg of each ascorbic acid, plant extract, H@Ag-NPs, and H@Au-NPs were dissolved in 1 mL absolute methanol and vortexed (1 min for ascorbic) or sonicated for 15 min (for NPs). Ascorbic acid, H@Ag-NPs, and H@Au-NPs were serially diluted two-fold in 96-well plates (1000, 500, 250, 125, and 62.5 µg/mL). A blank well was set as the negative control. An amount of 100 µL/well of DPPH (0.004 g/mL) was added, and the plates were incubated for 30 min in the dark. After that, the plates were shaken using a plate shaker for 1 min, and the absorbance was recorded at 517 nm using an ELISA plate reader (Bio-Rad, USA) [41].

FRAP Assay

The antioxidant activity of 2 mg/mL of H. salicornicum, H@Ag-NPs, and H@Au-NPs was examined using a FRAP assay. The 2,4,6-Tri(2-pyridyl)-s-triazine (TPTZ) reagent was freshly prepared (300 mM acetate buffer, pH = 3.6), and 10 mM TPTZ was suspended in 40 mM HCl and 20 mM FeCl3 at a ratio of 10:1:1 (v:v:v), respectively. In a 96-well plate, 10 µL of each treatment was mixed with 190 µL of TPTZ. The plates were incubated in the dark at ambient temperature for 30 min. Afterward, the plates were read using a plate reader at 593 nm [20,47].

2.2.8. Statistical Analysis

Data were collected from three independent triplicates and are presented as the mean ± SEM. Statistical significance was determined using GraphPrism software version 9 via one-way ANOVA analysis. ImageJ software (National Institutes of Health, Bethesda, MD, USA) was used to measure NP particle diameter, and Origin 8 (OriginLab Corporation, Northampton, MA, USA) was used to draw all physicochemical analysis data.

3. Results

3.1. GC-MS Analysis of Haloxylon Salicornicum

The GC-MS analysis demonstrated that 51 peaks for H. salicornicum correlated to 36 biomolecules (Figure 1 and Table 1). These 36 volatile phytocomponents included terpenes and their derivatives: alcohol, aldehyde, and ketone of terpenoids, fatty acids and their ester, aliphatic and aromatic hydrocarbons, and carboxylic acids. These derivatives may act as reducing and capping agents during the synthesis process for H@Ag-NPs and H@Au-NPs [48]. Monoterpenoids and sesquiterpenoids are potent contributors in Ag-NP synthesis and may act as surface activators that participate in the reduction or/and stabilization process of NPs [49,50]. Moreover, the existence of functional groups, such as C=C, C-C, C-O, –C=O, CH2, CH3, –OH, C-H, CH3-C-CH3, –C–O–C and –C–N groups, in the terpenoid structure determine their role as reductants and stabilizers [51,52,53,54]. Many H. salicornicum biomolecules are important plant metabolites, such as 1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-1-vinylcyclohexane), (1R-trans)-, cyclohexane, 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-, (1R,2R,4S)-rel-, beta-longipinene; anti-inflammatory agents, such as aromandendrene; and antioxidant agents such as alpha-copaene and (-)-globulol, etc. [55,56]. Ullah et al. reported that H. salicornicum extracts contain the biomolecules 5-butoxy-2-pentene (55.510%), 2,3-dihydro-3,5-dihydroxy-6-methyl-4h-pyran-4-one (14.640%), D-allose (10.080%) and oxalic acid [57]. Our findings showed that H. salicornicum extracts contain a variety of plant metabolites that may have therapeutic activity against different diseases.

3.2. Ag-NP and Au-NP Synthesis

During H@Ag-NP synthesis, the color of the solution transformed from pale yellow to dark yellow after 1 h of incubation in the light, then to faint reddish brown after 2 h. Finally, the solution turned a dark reddish-brown color that was stable after 24 h (Figure 2). The color of the H@Au-NPs was reddish pink after 1 h of synthesis and was stable during the incubation time. The wavelengths of H@Ag-NPs and H@Au-NPs were 435.5 nm [58] and 530.3 nm [59], respectively, indicating the successful synthesis of both NPs. The wavelength of Ag-NPs ranged between 400 and 450 nm [60], while Au-NPs ranged from 500 to 550 nm [61]. The maximum SPR for NPs depends on the electron charge density on the NP surface, particle size, shape, metal type, composition, etc. [62]. Smaller size NPs showed a decrease in their SPR values due to the phase changes resulting from the increased rate of electron-surface collisions compared to larger particles. Increments in NP size shift their wavelength and surge their intensity. The SPR of both H@AgNPs and H@Au-NPs indicate that these NPs have a median NP size. Chelly et al. synthesized Ag- and Au-NPs using a methanolic extract of Rumex roseus, which have SPR at 429 and 549 nm, respectively [63]. Lomelí-Rosales et al. synthesized Ag- and Au-NPs using aqueous extracts from the root, stem, and leaf of Capsicum chinense [20]. It was found that the SPR of Au-NPs synthesized using root, stem, and leaf was 553 nm, 548 nm, and 523 nm, respectively, whereas the SPR of Ag-NPs synthesized using the leaf was 430 nm. The scholar established the stability assay and reported that the stability of Ag-NPs was higher than that of Au-NPs.

3.2.1. XRD Analysis

XRD analysis was performed to detect the crystalline nature and crystal size of both H@Ag- and H@Au-NPs. The diffractogram has been compared with the standard powder diffraction card of JCPDS silver and gold files no. 04-0783 and 04-0784, respectively. The XRD graphs of H@Ag-NPs exhibited six diffraction peaks at 2θ of 27.86°, 32.18°, 38.1°, 46.1°, 54.6°, 57.4°, and 76.7°, corresponding to 2 1 0, 1 2 2, 1 1 1, 2 3 1, 1 4 2, 2 4 1, and 311. H@Au-NPs exhibited four diffraction peaks at 2θ of 38.4°, 44.2°, 64.5°, and 77.4°, corresponding to 1 1 1, 2 0 0, 2 2 0, and 3 1 0. These data indicate the crystallinity of both H@Ag-NPs and H@Au-NPs (Figure 3). The Scherrer equation, D = (kλ)/(β cos θ), was utilized to detect the crystallite size (D) of the most intense peak at 2ϴ of 32.0 and 38.2 for H@Ag-NPs and H@Au-NPs, respectively. H@Ag-NPs and H@Au-NPs crystallite sizes (D) were found to be 16.0 and 5.8 nm, respectively. The crystal size values of both NPs were in accordance with the nanosize of H@Ag-NPs and H@Au-NPs measured by ImageJ software using TEM micrographs. Arshad et al. synthesized Ag-NPs using Salvadora persica root extract and reported their 2θ at 27.86°, 32.34°, 38.2°, 46.2°, 54.74°, 57.3°, and 76.72°, which correlate to the lattice planes of 210, 122, 111, 231, 142, 241, and 311 [64]. Ssekatawa et al. synthesized Ag-NPs using Camellia sinensis extract and found that the XRD graphs had nine peaks at 2θ of 27.9°, 32.2°, 38.2°, 44.4°, 46.3°, 54.8°, 57.6°, 64.5°, and 77.4° [65]. The authors reported that 38.2°, 44.4°, 64.5°, and 77.4° corresponded to the crystal planes of Ag-NPs at 111, 200, 220, and 311, while the other peaks corresponded to phytochemicals on the NP surface. Au-NPs synthesized using methanolic extracts from Moringa oleifera leaves had XRD graphs at 2θ of 38.3, 44.4, 64.5, and 77.5 that corresponded to 111, 200, 220, and 311 of the face-centered cubic lattice [43].

3.2.2. FTIR

FTIR demonstrated that the functional groups of biomolecules exist in the plant extract, H@Ag-NPs, and H@Au-NPs (Figure 4 and Table 2). The IR peaks of H. salicornicum extract showed 12 peaks at 3368.04, 1634.5, 1467.1, 1409.01, 1330.7, 1251.4, 1093.8, 907.4, 829.9, 721.2, 609.7, and 500.0 cm−1. IR peaks of 3368.04 and 1634.5 cm−1 corresponded to strong, broad O-H stretching of alcohol and medium N-H bending of amines, respectively, while peaks at 1467.1 and 1409.01 cm−1 represented medium C-H bending of alkane and medium O-H bending of alcohol or carboxylic acid, respectively. FTIR peaks at 1330.7, 1251.4, and 1093.8 were related to strong C-N stretching of aromatic amine, strong C-O stretching of aromatic ester or alkyl aryl ether, and strong C-O stretching of a secondary alcohol. Peaks at 907.4, 829.9, 721.2, 609.7, and 500.0 cm−1 corresponded to strong C=C bending alkene, strong C-Cl stretching of halocompound, strong C=C bending of alkene, strong C-Cl and C-I stretching of halocompound, respectively. The IRs of H@Ag-NPs were located at nine peaks of 3424.7 [66], 2928.8 [67], 2861.8 [68], 1634.0 [69], 1510.3, 1386.5, 1240.2, 1059.7 [70], and 587.6 cm−1, corresponding to strong, broad O-H stretching of alcohol; medium C-H stretching of alkane; medium C-H stretching of alkane; medium C=C stretching of alkene; strong N-O stretching of nitrocompound; medium C-H stretching of aldehyde; medium C-N stretching of amine; strong C-O stretching of primary alcohol; and strong C-Cl stretching of halocompound. FTIR peaks of H@Au-NPs occurred at 3424.7, 2928.8, 2861.8, 1747.4 [68], 1634.0, 1465.9 [68], 1231.0 [70], 1173.2 [71], 1059.7 [70], and 582.0 cm−1, corresponding to strong, broad O-H stretching of alcohol; medium C-H stretching of alkane; medium C-H stretching of alkane; strong C=O stretching of esters or δ-lactone; strong C=C stretching of alkene; medium C-H bending of alkane; medium C-N stretching of amine; strong C-O stretching of tertiary alcohol or ester; strong C-O stretching of primary alcohol; and strong C-Cl stretching of halocompound. By analyzing the IR spectra of both plant extract and NPs, it was found that the main functional groups on the NPs’ surface were O-H or C-O of alcohol, N-O of nitrocompound, C-N of amine and C-H of hydrocarbons (essential oils/terpenes), suggesting that these biomolecules might mitigate the synthesis process of NPs as reducing and capping agents [72]. Interestingly, the IR of H@Ag-NPs and H@Au-NPs have the same spectra at 3424.7, 2928.8, 2861.8, 1634.0, and 1059.7 cm−1, suggesting that these biomolecules might be the main and essential plant metabolities (defenders) responsible for fabricating the bulk materials into nanoscale matter. Moreover, the existence of other spectra rather than the main components on both NP surfaces varied depending on the type, composition, and structure of the metals. For instance, the surface of H@Ag-NPs was found to have three other spectra, including 1510.3, 1386.5, and 1240.2 cm−1, whereas H@Au-NPs had four spectra, 1747.4, 1465.9, 1231.0, and 1173.2 cm−1. This variation in the functional groups on the NP surface may be a response to the physicochemical characteristics of the metals. The IR spectra was in correspondence with data from the GC-MS analysis, in which the volatile phytocomponents of H. salicornicum were terpenes and its derivative alcohol, aldehyde, ketone of terpenoids, fatty acids and its ester, aliphatic and aromatic hydrocarbons, and carboxylic acids with the main functional groups of C=O, C-O, C-H, O-H, C=N, C-Cl, etc.

3.2.3. Transmission Electron Microscope

TEM micrographs showed that H@Ag-NPs have a uniform spherical shape coated with plant matrix (organic compounds), whereas H@Au-NPs have a spherical shape with a few oval and triangular shapes (Figure 5A–D). The frequency distribution of both H@Ag-NPs and H@Au-NPs demonstrated that they have an average nanodiameter of 19.1 ± 0.8 nm and 8.1 ± 0.3 nm and nanosize range of 6 to 42 and 1 to 12 nm, respectively (Figure 5E). Singh et al. synthesized Ag-NPs and Au-NPs using Ligustrum vulgare berry extract and reported that Ag-NPs and Au-NPs have various shapes with nanosize ranges of 50–200 and 20–70 nm, respectively [73].

3.2.4. Scanning Electron Microscope and EDX

SEM micrographs showed that both H@AgNPs and H@Au-NPs have spherical shapes (Figure 6A,B). EDX and mapping analyses revealed that the dominant chemical composition of H@AgNPs was silver (Ag; 88.61%) at 3 keV [41]. Other elements were detected, including chloride (7%), carbon (2.5%), copper (1%), oxygen (0.58%), and aluminum (0.14%).
The most distributed element in H@Au-NP samples was Au at 2.3 and 9.7 keV (85%), followed by copper (5.5%), carbon (3.9%), zinc (3.7%) and aluminum (0.21%) (Figure 6C–F and Table 3) [74]. Additionally, map analysis exhibited other trace elements, including oxygen and Na, in the H@Au-NPs sample. It was found that C, Cl, O, etc., are impurities derived from plant materials and coated NPs; these elements are important for plant growth and metabolism.

3.2.5. Zeta Potential and DLS Analysis

The zeta potential of H@Ag-NPs and H@Au-NPs was −24.0 and −24.4 mV, respectively, whereas the H@Ag-NP hydrodynamic diameter (HD) was 184.7 nm with a polydispersity index (PDI) of 0.411. H@Au-NPs had two HDs at 295.4 and 56.4 nm with a PDI of 0.47 (Figure 7A–D). The great negativity of both H@Ag-NPs and H@Au-NPs indicated that these NPs demonstrate colloidal stability; however, the high HD values for both H@Ag-NPs and H@Au-NPs may be due to saturated biomolecules and water molecules of the aqueous system coating the NPs. Ag- and Au-NPs fabricated using Ligustrum vulgare had HDs of 542.6 nm with a PDI of 0.479 and 292.3 nm with a PDI of 0.3, with zeta potentials of −18.7 and −20.8 mV, respectively [73].

3.3. Anticancer Activity of Ag-NPs

The antiproliferative activity of H@Ag-NPs in the four colon cancer cell lines (Sw480, Sw620, HCT-116, and Caco-2) was higher than that of H@Au-NPs and 5-FU. H@Ag-NPs caused 50% inhibition in the growth of Sw480, HCT-116, Caco-2, and Sw620 cells at concentrations of 20.4, 28.5, 29.8, and 50.23 µg/mL in the respective cell lines. The IC50 of H@Au-NPs against all tested malignant cell lines was above the tested concentration of 500 µg/mL. Although H@Ag-NPs were cytotoxic to the malignant cells, they also had a cytotoxic effect on nonmalignant cells with an IC50 of 5.0 and 9.0 µg/mL against HFs and Vero, respectively (Figure 8A–F). The IC50 of 5-FU against Sw480, Sw620, HCT-116, Caco-2, HFs, and Vero was 49.2, 190.0, 317.5, 20.57, 32.4, and 33.12, respectively (Figure 9). Intriguingly, Sw480 was the most sensitive to H@Ag-NPs, whereas Sw620 was the least permeable to H@Ag-NPs. Both HCT-116 and Caco-2 had similar responses to the same dose of H@Ag-NPs. These data indicate that the antiproliferative activity of H@Ag-NPs was cell type-dependent, which may be due to the differences in the cellular metabolic state that influences the cellular charge and interactions with charged NPs. The greater toxicity of H@Ag-NPs could be due to the higher reactivity of silver ions, which enables them to interact with cellular molecules such as proteins, enzymes, and antioxidants to induce intracellular oxidative stress resulting in enhanced apoptosis. H@Au-NPs showed low toxicity against all malignant and nonmalignant cells at 500 µg/mL. Only 20% of Sw480 cells were inhibited at 500 µg/mL, while 23% of Sw620 cells died at 62.5 µg/mL. H@Au-NPs suppressed the growth of Caco-2 cells by 20% at 500 µg/mL and showed no effect on HCT-116 cells (100% viability at 500 µg/mL). H@Au-NPs inhibited 20% and 16% of HF and Vero cell growth at 500 µg/mL, respectively. The biocompatibility of H@Au-NPs against malignant or nonmalignant cells may be due to their biological inertness or/and the ability of the various cell types to regulate cellular uptake of the H@Au-NPs. Moreover, the low percentage of cell death caused by H@Au-NPs may be due to the plant-derived corona coating the H@Au-NP surface and not due to the Au-NP itself. Conversely, the low antiproliferative activity percentage may be due to the low concentration of corona biomolecules. The concentration may not have been high enough to enhance cellular toxicity. The low antiproliferative activity percentage also may have been due to the absence of active metabolites with significant anticancer activity on the NP surface. Au-NPs have a high surface free energy that enables them to absorb/desorb other molecules, resulting in protein corona formation. These coronas are identified by cells and play a significant role in enhancing the biological activity of NPs by interacting with other molecules in the biological fluids and extracellular matrix. These interactions consequently influence the cellular uptake, biodistribution, signaling, circulation lifetime, and toxicity of the NP [75,76]. Ag- and Au-NPs synthesized using Commelina nudiflora aqueous leaf extracts showed antiproliferative activity against HCT-116, with an IC50 of 200 and 100 µg/mL [77], whereas Ag-NPs synthesized using Cornus officinalis extract showed poor toxicity against Sw620 cell lines. Baran et al. reported that the IC50 value for the Ag-NPs synthesized using Cicer arietinum L. occurred at a concentration of 200 mg/mL in Caco-2 cell lines [78].

3.4. Antimicrobial Activity of Ag-NPs

The biocidal activity of H@Ag-NPs, H@Au-NPs, H. salicornicum extract, and ciprofloxacin was tested against S. aureus, B. cereus, E. coli, and K. pneumoniae using agar well diffusion and microdilution methods. The results of MIC and MBC revealed that H@Ag-NPs had the greatest antibacterial and inhibitory activity at a low concentration against the tested bacteria when compared to the other treatments (Table 4). The highest MIC and MBC of H@Ag-NP values were reported against E. coli (7.8 and 15.6 µg/mL), followed by K. pneumoniae and B. cereus (3.9 and 7.8 µg/mL), then S. aureus (1.9 and 3.9 µg/mL). These data demonstrate that S. aureus was the most permeable to H@Ag-NPs compared to other tested microbes. An amount of 500 µg/mL of H@Au-NPs and H. salicornicum extract was not adequate for inhibiting bacterial growth. The agar well diffusion data showed that the biocidal activity of the tested treatments could be represented as follows: ciprofloxacin > H@Ag-NPs > H. salicornicum extract > H@Au-NPs (Figure 10). An amount of 1000 µg/mL H@Ag-NPs had great inhibitory activity against Gram-positive bacteria compared to Gram-negative bacteria, and S. aureus (17.0 ± 0.1 mm) was the most sensitive to H@Ag-NPs, followed by B. cereus (13.4 ± 0.2 mm), K. pneumoniae (13.3 ± 0.4 mm), and E. coli (13.0 ± 0.0 mm). The activity of 1000 µg/mL H@Ag-NPs against the tested bacteria was half that of ciprofloxacin against the same bacteria (Table 5). The greater activity of H@Ag-NPs against Gram-positive vs. Gram-negative bacteria may be attributed to the nature of the NPs’ charges, in which the negative charge of H@Ag-NPs allows the electrostatic attraction to positively charged bacterial cell walls more than negatively charged bacterial cell walls [79]. Consequently, more adsorbed NPs on the bacterial membrane cause local stress on the bacterial cell wall, resulting in membrane disruption and allowing entrance to more NPs that cause cellular dysfunction via interactions with DNA, proteins, and enzymes and subsequent cell death [80]. On the other hand, 1000 µg/mL H@Au-NPs showed no inhibitory activity (zero IZ) against both Gram-positive and Gram-negative bacteria. These results may be attributed to i) the Au-NPs being biologically inert and having low or no biocidal activity against microbes, or ii) the smaller size of H@Au-NPs (2 to 12 nm), which may enable bacterial cells to efflux NPs or decrease NP permeability and cellular entry [81]. An amount of 20 mg/mL of H. salicornicum aqueous extract had lower biocidal activity compared to H@Ag-NPs. The antibacterial activity of H. salicornicum was greater against Gram-positive bacteria than Gram-negative bacteria. The greatest activity of H. salicornicum was against S. aureus (12.0 ± 0.10 mm), while the lowest activity was against both E. coli (9.8 ± 0.3 mm) and K. pneumoniae (9.9 ± 0.6 mm) (Table 5). Gram-negative bacteria have rigid, thick, and selectively permeable cell walls, enabling these bacteria to mitigate the access of many therapeutic molecules into the bacterial cells [82,83]. Thus, Gram-negative bacteria may be less permeable to plant extracts when compared to Gram-positive bacteria. Moreover, the pharmacokinetics and pharmacodynamics of the plant biomolecules inside the bacterial cells regulate their therapeutic activity.
The biocidal activity of H@Ag-NPs was greater than that caused by plant extracts against the same microbes. This may be attributed to the drug delivery capacity of Ag-NPs to deliver plant biomolecules to the target cells to increase the probability of inducing cell death pathways. Moreover, the therapeutic potential of Ag ions itself may be a significant cause of bacterial growth inhibition. Ag- and Au-NPs synthesized using Capsicum chinense have been tested against S. aureus, Enterococcus faecalis, E. coli, and Serratia marcescens [20]. In previous studies, Au-NPs showed no antibacterial activity, whereas 4.0 mM of Ag-NPs inhibited S. aureus, E. faecalis, E. coli, and S. marcescens growth with an IZ diameter of 10.22 ± 0.46, 5.38 ± 0.26, 8.64 ± 0.12, and 9.96 ± 0.43 mm, respectively. The antibacterial influence of purified Ag-NPs synthesized using Morinda citrifolia L. was also tested against E. coli, P. auerginosa, K. pneumoniae, E. aerogens, B. cereus, and Enterococcus sp. and was found to inhibit bacterial growth of E. coli, P. auerginosa, K. pneumoniae, E. aerogens, B. cereus, and Enterococcus sp. with an IZ of 7, 8, 0, 7, 0, and 7 mm. Plant extract showed 0 IZ against all tested bacteria [84].

3.5. Antioxidant Activity of Ag-NPs

The scavenging activity of H. salicornicum extract, H@Ag-NPs, and H@Au-NPs was examined using FRAP and DPPH assays. The FRAP data revealed that among the tested treatments, H@Ag-NPs have the highest antioxidant activity with TEAC of 506.6 ± 32.7 μM TE/mg, followed by H@Au-NPs and plant extract with TEAC of 173.75 ± 15.3 and 109.4 ± 9.7 μM TE/mg, respectively (Figure 11A). Similarly, the DPPH assay revealed that the scavenging activity of H. salicornicum extract, H@Ag-NPs, and H@Au-NPs occurred in a dose-dependent manner. An amount of 1 mg/mL H@Ag-NPs had the greatest scavenging activity (63.1%) compared to H@Au-NPs (17.4%) and plant extract (21.5%) (Figure 11B). The greater antioxidant activity of H@Ag-NPs compared to other treatments may be due to the higher reactivity and surface chemistry of silver ions that enable the binding of more bioactive antioxidant molecules on the NPs’ surface. Lomelí-Rosales et al. determined the antioxidant activity of plant extracts and their biosynthesized Ag- and Au-NPs using ABTS, FRAP, and DPPH assays [20]. They found that the reducing activity of plant extract was 335.8 ± 51.3, 31.4 ± 5.4, and 120.9 ± 12.6 µM TE when measured by ABTS, DPPH, and FRAR analyses, respectively. Moreover, the inhibitory activity for both Ag-and Au-NPs decreased by 60.7% and 44.7% for ABTS and 34.5% and 52.1% for FRAP compared to plant extracts, respectively. Both NPs also showed no significant change in DPPH activity compared to plant extract. The authors claimed that the reduction in the scavenging activity of NPs compared to plant extract was due to the consumption of plant biomolecules in the synthesis process of NPs. Ag- and Au-NPs synthesized using Plumbago zeylanica showed greater scavenging activity against DPPH with an inhibition percentage of 87.34% and 78.17%, respectively, compared to plant extract and an inhibition percentage of 71.16% and 74.88%, respectively, compared to standard butylated hydroxytoluene [85].

4. Conclusions

These findings demonstrated the potential use of H. salicornicum aqueous extract in synthesizing H@Ag-NPs and H@Au-NPs for the first time. GC-MS and FTIR data revealed that proteins, alcohol, and hydrocarbons (essential oils/terpenes) were the main phytochemicals in plant extract that might be responsible for reducing and stabilizing NPs. Our findings suggest that the variation in functional group compositions on the surface of NPs synthesized from the same plant may be due to responses to metal physicochemical characteristics, including the metal type, composition, and structure. The resultant H@Ag-NPs and H@Au-NPs had mainly uniform spherical shapes. H@Au-NPs also had some oval and triangular shapes. The size of H@Au-NPs (8.1 ± 0.3 nm) was smaller than that of H@Ag-NPs (19.1 ± 0.8 nm). In a colloidal system, H@Ag-NPs and H@Au-NPs have HD values of 184.7 nm, while H@Au-NPs had a HD of 56.4 and 295.4 nm. The surface of both NP types was negatively charged at about −24 mV. XRD, EDx, and mapping analyses indicated the crystallinity and the dominant distribution of silver and gold NPs in the samples. H@Ag-NPs showed great anticancer, antibacterial, and antioxidant activity compared to H@Au-NPs and plant extract. Although H@Au-NPs were smaller, their reactivity against cancer and microbial cells was weak, suggesting that the chemical properties, metal structure, quantity, and chemistry of the functional groups on the NP surface may influence their reactivity. Of the cancer cell types tested, Sw480 was the most sensitive to H@Ag-NPs, whereas Sw620 was the least permeable. These data indicated that the antiproliferative activity of H@Ag-NPs was cell response-dependent and may be affected by many factors, such as the cellular metabolic state that influences the cellular charge and interactions with charged NPs. Similarly, S. aureus (17.0 ± 0.12 mm) was the most sensitive bacteria to H@Ag-NPs, and E. coli (13.0 ± 0. mm) was the most resistant. The greater activity of H@Ag-NPs against Gram-positive vs. Gram-negative bacteria could be attributed to the nature of the NP charge, such that the negative charge of H@Ag-NPs allowed them to be electrostatically attracted to positively charged bacterial cell walls more than negatively charged bacterial cell walls. DPPH and FRAP assays showed that H@Ag-NPs exhibited greater scavenging and reducing activity against free radicals and FRAP reagents compared to plant extract and H@Au-NPs, suggesting that the higher reactivity and surface chemistry of silver ions may enable more plant-bioactive antioxidant molecules to bind on the NP surface to aid in increasing their antioxidant activity. The current data suggest that the use of H. salicornicum for the synthesis of Ag- and Au-NPs with a smaller size, uniform shape, and biological efficacy is an eco-benign, sustainable, fast, and effective method of NP production. Of note, the lower toxicity of H@Au-NPs enables these NPs to be used for drug delivery of traditional drugs. More investigations are required to understand the reactivity of NPs synthesized using H. salicornicum and the role of phytochemical functional groups on the NP surface to enhance the therapeutic activity of NPs. Performing intensive studies on the toxicological activity of H@Au-NPs may allow these NPs to be implemented for drug delivery at the clinical level.

Author Contributions

Conceptualization, R.S.H., M.A.A. (Mohamed Abdelaal Ali) and M.M.B.-M.; methodology, R.S.H., M.A.A. (Mohamed Abdelaal Ali) and M.M.B.-M.; software, R.S.H.; validation R.S.H., M.A.A. (Mohamed Abdelaal Ali) and M.M.B.-M.; formal analysis, R.S.H.; investigation, R.S.H., M.A.A. (Mohamed Abdelaal Ali) and M.M.B.-M.; resources, M.A.A. (Mohamed Abdelaal Ali), M.A.M. and M.M.B.-M.; data curation, R.S.H. and M.A.A. (Mohamed Abdelaal Ali); writing—original draft preparation, R.S.H.; writing—review and editing, R.S.H.; visualization, R.S.H. and M.A.A. (Mohamed Abdelaal Ali); supervision, M.M.B.-M.; project administration, M.M.B.-M., H.E.A., M.A.M. and M.A.A. (Mariam Abdulaziz Alkhateeb); funding acquisition, H.E.A., M.A.A. (Mariam Abdulaziz Alkhateeb) and M.A.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University through the Research Groups Program (grant no. RGP-1441-0030).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Additional data to those presented here are available from the corresponding author upon reasonable request.

Acknowledgments

This work was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University through the Research Groups Program (grant no. RGP-1441-0030).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dauthal, P.; Mukhopadhyay, M. Noble metal nanoparticles: Plant-mediated synthesis, mechanistic aspects of synthesis, and applications. Ind. Eng. Chem. Res. 2016, 55, 9557–9577. [Google Scholar] [CrossRef]
  2. Khan, F.; Shariq, M.; Asif, M.; Siddiqui, M.A.; Malan, P.; Ahmad, F. Green nanotechnology: Plant-mediated nanoparticle synthesis and application. Nanomaterials 2022, 12, 673. [Google Scholar] [CrossRef] [PubMed]
  3. Kidd, P.S.; Álvarez-López, V.; Becerra-Castro, C.; Cabello-Conejo, M.; Prieto-Fernández, Á. Potential role of plant-associated bacteria in plant metal uptake and implications in phytotechnologies. Adv. Bot. Res. 2017, 83, 87–126. [Google Scholar]
  4. Mustapha, T.; Misni, N.; Ithnin, N.R.; Daskum, A.M.; Unyah, N.Z. A review on plants and microorganisms mediated synthesis of silver nanoparticles, role of plants metabolites and applications. Int. J. Environ. Res. Public Health 2022, 19, 674. [Google Scholar] [CrossRef] [PubMed]
  5. Yang, X.; Feng, Y.; He, Z.; Stoffella, P.J. Molecular mechanisms of heavy metal hyperaccumulation and phytoremediation. J. Trace Elem. Med. Biol. 2005, 18, 339–353. [Google Scholar] [CrossRef]
  6. Bisht, S.; Sharma, V.; Kumari, N. Biosynthesized magnetite nanoparticles from Polyalthia longifolia leaves improve photosynthetic performance and yield of Trigonella foenum-graecum under drought stress. Plant Stress 2022, 5, 100090. [Google Scholar] [CrossRef]
  7. Prabha, S.; Durgalakshmi, D.; Rajendran, S.; Lichtfouse, E. Plant-derived silica nanoparticles and composites for biosensors, bioimaging, drug delivery and supercapacitors: A review. Environ. Chem. Lett. 2021, 19, 1667–1691. [Google Scholar] [CrossRef]
  8. de Morais, M.G.; Vaz, B.d.S.; de Morais, E.G.; Costa, J.A.V. Biologically active metabolites synthesized by microalgae. BioMed Res. Int. 2015, 2015, 835761. [Google Scholar] [CrossRef]
  9. Sidhu, A.K.; Verma, N.; Kaushal, P. Role of biogenic capping agents in the synthesis of metallic nanoparticles and evaluation of their therapeutic potential. Front. Nanotechnol. 2022, 3, 105. [Google Scholar] [CrossRef]
  10. Chugh, R.; Kaur, G. A mini review on green synthesis of nanoparticles by utilization of Musa-balbisiana waste peel extract. Mater. Today Proc. 2022. [Google Scholar] [CrossRef]
  11. Manousaki, A.; Jancheva, M.; Grigorakis, S.; Makris, D.P. Extraction of antioxidant phenolics from agri-food waste biomass using a newly designed glycerol-based natural low-transition temperature mixture: A comparison with conventional eco-friendly solvents. Recycling 2016, 1, 194–204. [Google Scholar] [CrossRef]
  12. Chung, I.-M.; Park, I.; Seung-Hyun, K.; Thiruvengadam, M.; Rajakumar, G. Plant-mediated synthesis of silver nanoparticles: Their characteristic properties and therapeutic applications. Nanoscale Res. Lett. 2016, 11, 40. [Google Scholar] [CrossRef] [PubMed]
  13. Skóra, B.; Krajewska, U.; Nowak, A.; Dziedzic, A.; Barylyak, A.; Kus-Liśkiewicz, M. Noncytotoxic silver nanoparticles as a new antimicrobial strategy. Sci. Rep. 2021, 11, 13451. [Google Scholar] [CrossRef] [PubMed]
  14. Aldewachi, H.; Chalati, T.; Woodroofe, M.; Bricklebank, N.; Sharrack, B.; Gardiner, P. Gold nanoparticle-based colorimetric biosensors. Nanoscale 2018, 10, 18–33. [Google Scholar] [CrossRef]
  15. Si, P.; Razmi, N.; Nur, O.; Solanki, S.; Pandey, C.M.; Gupta, R.K.; Malhotra, B.D.; Willander, M.; de la Zerda, A. Gold nanomaterials for optical biosensing and bioimaging. Nanoscale Adv. 2021, 3, 2679–2698. [Google Scholar] [CrossRef]
  16. Vangijzegem, T.; Stanicki, D.; Laurent, S. Magnetic iron oxide nanoparticles for drug delivery: Applications and characteristics. Expert Opin. Drug Deliv. 2019, 16, 69–78. [Google Scholar] [CrossRef]
  17. Li, F.-Y.; Chung, Y.-C. Fabrication of “electroactive cells” using bio-inspired polydopamine-derived carbon nanoparticles for manipulation of cells with electrical stimulation. Front. Bioeng. Biotechnol. 2022, 10, 949308. [Google Scholar] [CrossRef]
  18. Akhtar, M.S.; Panwar, J.; Yun, Y.-S. Biogenic synthesis of metallic nanoparticles by plant extracts. ACS Sustain. Chem. Eng. 2013, 1, 591–602. [Google Scholar] [CrossRef]
  19. Wang, L.; Hasanzadeh Kafshgari, M.; Meunier, M. Optical properties and applications of plasmonic-metal nanoparticles. Adv. Funct. Mater. 2020, 30, 2005400. [Google Scholar] [CrossRef]
  20. Lomelí-Rosales, D.A.; Zamudio-Ojeda, A.; Reyes-Maldonado, O.K.; López-Reyes, M.E.; Basulto-Padilla, G.C.; Lopez-Naranjo, E.J.; Zuñiga-Mayo, V.M.; Velázquez-Juárez, G. Green Synthesis of Gold and Silver Nanoparticles Using Leaf Extract of Capsicum chinense Plant. Molecules 2022, 27, 1692. [Google Scholar] [CrossRef]
  21. AlSalhi, M.S.; Devanesan, S.; Alfuraydi, A.A.; Vishnubalaji, R.; Munusamy, M.A.; Murugan, K.; Nicoletti, M.; Benelli, G. Green synthesis of silver nanoparticles using Pimpinella anisum seeds: Antimicrobial activity and cytotoxicity on human neonatal skin stromal cells and colon cancer cells. Int. J. Nanomed. 2016, 11, 4439. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Devanesan, S.; AlSalhi, M.S. Green synthesis of silver nanoparticles using the flower extract of Abelmoschus esculentus for cytotoxicity and antimicrobial studies. Int. J. Nanomed. 2021, 16, 3343. [Google Scholar] [CrossRef] [PubMed]
  23. Hosny, M.; Fawzy, M.; El-Fakharany, E.M.; Omer, A.M.; Abd El-Monaem, E.M.; Khalifa, R.E.; Eltaweil, A.S. Biogenic synthesis, characterization, antimicrobial, antioxidant, antidiabetic, and catalytic applications of platinum nanoparticles synthesized from Polygonum salicifolium leaves. J. Environ. Chem. Eng. 2022, 10, 106806. [Google Scholar] [CrossRef]
  24. Liang, Y.; Demir, H.; Wu, Y.; Aygun, A.; Tiri, R.N.E.; Gur, T.; Yuan, Y.; Xia, C.; Demir, C.; Sen, F. Facile synthesis of biogenic palladium nanoparticles using biomass strategy and application as photocatalyst degradation for textile dye pollutants and their in-vitro antimicrobial activity. Chemosphere 2022, 306, 135518. [Google Scholar] [CrossRef]
  25. Ansari, A.; Siddiqui, V.U.; Rehman, W.U.; Akram, M.K.; Siddiqi, W.A.; Alosaimi, A.M.; Hussein, M.A.; Rafatullah, M. Green synthesis of TiO2 nanoparticles using Acorus calamus leaf extract and evaluating its photocatalytic and in vitro antimicrobial activity. Catalysts 2022, 12, 181. [Google Scholar] [CrossRef]
  26. Haydar, M.S.; Das, D.; Ghosh, S.; Mandal, P. Implementation of mature tea leaves extract in bioinspired synthesis of iron oxide nanoparticles: Preparation, process optimization, characterization, and assessment of therapeutic potential. Chem. Pap. 2022, 76, 491–514. [Google Scholar] [CrossRef]
  27. Vinothkanna, A.; Mathivanan, K.; Ananth, S.; Ma, Y.; Sekar, S. Biosynthesis of copper oxide nanoparticles using Rubia cordifolia bark extract: Characterization, antibacterial, antioxidant, larvicidal and photocatalytic activities. In Environmental Science and Pollution Research; Springer: Berlin/Heidelberg, Germany, 2022; pp. 1–12. [Google Scholar]
  28. Mary, J.V.; Pragathiswaran, C.; Anusuya, N. Photocatalytic, degradation, sensing of Pb2+ using titanium nanoparticles synthesized via plant extract of Cissusquadrangularis: In-vitroanalysis of microbial and anti-cancer activities. J. Mol. Struct. 2021, 1236, 130144. [Google Scholar] [CrossRef]
  29. Mortazavi-Derazkola, S.; Hosseinzadeh, M.; Yousefinia, A.; Naghizadeh, A. Green Synthesis and Investigation of Antibacterial Activity of Silver Nanoparticles Using Eryngium bungei Boiss Plant Extract. J. Polym. Environ. 2021, 29, 2978–2985. [Google Scholar] [CrossRef]
  30. Happy, A.; Soumya, M.; Kumar, S.V.; Rajeshkumar, S.; Sheba, R.D.; Lakshmi, T.; Nallaswamy, V.D. Phyto-assisted synthesis of zinc oxide nanoparticles using Cassia alata and its antibacterial activity against Escherichia coli. Biochem. Biophys. Rep. 2019, 17, 208–211. [Google Scholar] [CrossRef]
  31. Gurunathan, S.; Han, J.W.; Kwon, D.-N.; Kim, J.-H. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Lett. 2014, 9, 373. [Google Scholar] [CrossRef]
  32. Hamida, R.S.; Ali, M.A.; Redhwan, A.; Bin-Meferij, M.M. Cyanobacteria–A Promising Platform in Green Nanotechnology: A Review on Nanoparticles Fabrication and Their Prospective Applications. Int. J. Nanomed. 2020, 15, 6033–6066. [Google Scholar] [CrossRef]
  33. Nagajyothi, P.; Cha, S.J.; Yang, I.J.; Sreekanth, T.; Kim, K.J.; Shin, H.M. Antioxidant and anti-inflammatory activities of zinc oxide nanoparticles synthesized using Polygala tenuifolia root extract. J. Photochem. Photobiol. B Biol. 2015, 146, 10–17. [Google Scholar] [CrossRef] [PubMed]
  34. Saratale, R.G.; Saratale, G.D.; Ahn, S.; Shin, H.-S. Grape pomace extracted tannin for green synthesis of silver nanoparticles: Assessment of their antidiabetic, antioxidant potential and antimicrobial activity. Polymers 2021, 13, 4355. [Google Scholar] [CrossRef] [PubMed]
  35. Marimuthu, S.; Rahuman, A.A.; Rajakumar, G.; Santhoshkumar, T.; Kirthi, A.V.; Jayaseelan, C.; Bagavan, A.; Zahir, A.A.; Elango, G.; Kamaraj, C. Evaluation of green synthesized silver nanoparticles against parasites. Parasitol. Res. 2011, 108, 1541–1549. [Google Scholar] [CrossRef] [PubMed]
  36. Thakar, M.A.; Jha, S.S.; Phasinam, K.; Manne, R.; Qureshi, Y.; Babu, V.H. X ray diffraction (XRD) analysis and evaluation of antioxidant activity of copper oxide nanoparticles synthesized from leaf extract of Cissus vitiginea. Mater. Today Proc. 2022, 51, 319–324. [Google Scholar] [CrossRef]
  37. Aygun, A.; Gulbagca, F.; Altuner, E.E.; Bekmezci, M.; Gur, T.; Karimi-Maleh, H.; Karimi, F.; Vasseghian, Y.; Sen, F. Highly active PdPt bimetallic nanoparticles synthesized by one-step bioreduction method: Characterizations, anticancer, antibacterial activities and evaluation of their catalytic effect for hydrogen generation. Int. J. Hydrog. Energy 2022, 48, 6666–6679. [Google Scholar] [CrossRef]
  38. Mundekkad, D.; Cho, W.C. Nanoparticles in clinical translation for cancer therapy. Int. J. Mol. Sci. 2022, 23, 1685. [Google Scholar] [CrossRef]
  39. Hamida, R.S.; Ali, M.A.; Goda, D.A.; Khalil, M.I.; Al-Zaban, M.I. Novel Biogenic Silver Nanoparticle-Induced Reactive Oxygen Species Inhibit the Biofilm Formation and Virulence Activities of Methicillin-Resistant Staphylococcus aureus (MRSA) Strain. Front. Bioeng. Biotechnol. 2020, 8, 433. [Google Scholar] [CrossRef]
  40. Jebril, S.; Fdhila, A.; Dridi, C. Nanoengineering of eco-friendly silver nanoparticles using five different plant extracts and development of cost-effective phenol nanosensor. Sci. Rep. 2021, 11, 22060. [Google Scholar] [CrossRef]
  41. Hamida, R.S.; Ali, M.A.; Almohawes, Z.N.; Alahdal, H.; Momenah, M.A.; Bin-Meferij, M.M. Green Synthesis of Hexagonal Silver Nanoparticles Using a Novel Microalgae Coelastrella aeroterrestrica Strain BA_Chlo4 and Resulting Anticancer, Antibacterial, and Antioxidant Activities. Pharmaceutics 2022, 14, 2002. [Google Scholar] [CrossRef]
  42. Hamida, R.S.; Abdelmeguid, N.E.; Ali, M.A.; Bin-Meferij, M.M.; Khalil, M.I. Synthesis of silver nanoparticles using a novel cyanobacteria Desertifilum sp. extract: Their antibacterial and cytotoxicity effects. Int. J. Nanomed. 2020, 15, 49. [Google Scholar] [CrossRef] [Green Version]
  43. Boruah, J.S.; Devi, C.; Hazarika, U.; Reddy, P.V.B.; Chowdhury, D.; Barthakur, M.; Kalita, P. Green synthesis of gold nanoparticles using an antiepileptic plant extract: In vitro biological and photo-catalytic activities. RSC Adv. 2021, 11, 28029–28041. [Google Scholar] [CrossRef]
  44. Hamida, R.S.; Ali, M.A.; Goda, D.A.; Al-Zaban, M.I. Lethal Mechanisms of Nostoc-Synthesized Silver Nanoparticles Against Different Pathogenic Bacteria. Int. J. Nanomed. 2020, 15, 10499. [Google Scholar] [CrossRef]
  45. Elshikh, M.; Ahmed, S.; Funston, S.; Dunlop, P.; McGaw, M.; Marchant, R.; Banat, I.M. Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants. Biotechnol. Lett. 2016, 38, 1015–1019. [Google Scholar] [CrossRef]
  46. Bin-Meferij, M.M.; Hamida, R.S. Biofabrication and antitumor activity of silver nanoparticles utilizing novel nostoc sp. Bahar M. Int. J. Nanomed. 2019, 14, 9019. [Google Scholar] [CrossRef] [PubMed]
  47. Benzie, I.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef]
  48. Panda, A.; Rangani, J.; Parida, A.K. Unraveling salt responsive metabolites and metabolic pathways using non-targeted metabolomics approach and elucidation of salt tolerance mechanisms in the xero-halophyte Haloxylon salicornicum. Plant Physiol. Biochem. 2021, 158, 284–296. [Google Scholar] [CrossRef]
  49. Song, J.Y.; Kim, B.S. Rapid biological synthesis of silver nanoparticles using plant leaf extracts. Bioprocess Biosyst. Eng. 2009, 32, 79–84. [Google Scholar] [CrossRef] [PubMed]
  50. Song, J.Y.; Jang, H.-K.; Kim, B.S. Biological synthesis of gold nanoparticles using Magnolia kobus and Diopyros kaki leaf extracts. Process Biochem. 2009, 44, 1133–1138. [Google Scholar] [CrossRef]
  51. Vijayaraghavan, K.; Nalini, S.K.; Prakash, N.U.; Madhankumar, D. One step green synthesis of silver nano/microparticles using extracts of Trachyspermum ammi and Papaver somniferum. Colloids Surf. B Biointerfaces 2012, 94, 114–117. [Google Scholar] [CrossRef] [PubMed]
  52. Prathna, T.; Chandrasekaran, N.; Raichur, A.M.; Mukherjee, A. Kinetic evolution studies of silver nanoparticles in a bio-based green synthesis process. Colloids Surf. A Physicochem. Eng. Asp. 2011, 377, 212–216. [Google Scholar] [CrossRef]
  53. Tripathy, A.; Raichur, A.M.; Chandrasekaran, N.; Prathna, T.; Mukherjee, A. Process variables in biomimetic synthesis of silver nanoparticles by aqueous extract of Azadirachta indica (Neem) leaves. J. Nanoparticle Res. 2010, 12, 237–246. [Google Scholar] [CrossRef]
  54. Khan, M.A.; Khan, T.; Nadhman, A. Applications of plant terpenoids in the synthesis of colloidal silver nanoparticles. Adv. Colloid Interface Sci. 2016, 234, 132–141. [Google Scholar]
  55. Thapa, P.; Prakash, O.; Rawat, A.; Kumar, R.; Srivastava, R.; Rawat, D.; Pant, A. Essential Oil Composition, Antioxidant, Anti-inflammatory, Insect Antifeedant and Sprout Suppressant Activity in Essential Oil From Aerial Parts of Cotinus coggygria Scop. J. Essent. Oil Bear. Plants 2020, 23, 65–76. [Google Scholar] [CrossRef]
  56. Su, Y.-C.; Hsu, K.-P.; Hua, K.-F.; Ho, C.-L. Composition, in vitro anti-inflammatory, antioxidant and antimicrobial activities of essential oils from leaf and twig parts of Cupressus cashmeriana. Nat. Prod. Commun. 2015, 10, 1934578X1501000837. [Google Scholar] [CrossRef]
  57. Ullah, R.; Alsaid, M.S.; Alqahtani, A.S.; Shahat, A.A.; Naser, A.A.; Mahmood, H.M.; Ahamad, S.R.; Al-Mishari, A.A.; Ahmad, S. Anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Haloxylon salicornicum aqueous fraction. Open Chem. 2019, 17, 1034–1042. [Google Scholar] [CrossRef]
  58. Dashora, A.; Rathore, K.; Raj, S.; Sharma, K. Synthesis of silver nanoparticles employing Polyalthia longifolia leaf extract and their in vitro antifungal activity against phytopathogen. Biochem. Biophys. Rep. 2022, 31, 101320. [Google Scholar] [CrossRef]
  59. Lin, Q.; Hong, X.; Zhang, D.; Jin, H. Biosynthesis of size-controlled gold nanoparticles using M. lucida leaf extract and their penetration studies on human skin for plastic surgery applications. J. Photochem. Photobiol. B Biol. 2019, 199, 111591. [Google Scholar] [CrossRef]
  60. Hung, N.D.; Nam, V.N.; ThiNhan, T.; Dung, T.T.N. Quantitative concentration determination of silver nanoparticles prepared by DC high voltage electrochemical method. Vietnam. J. Chem. 2018, 56, 553–558. [Google Scholar] [CrossRef]
  61. Dhara, S. Origin of shifts in the surface plasmon resonance frequencies for Au and Ag nanoparticles. Rev. Plasmon. 2015, 2016, 275–294. [Google Scholar]
  62. Mie, G. A contribution to the optics of turbid media, especially colloidal metallic suspensions. Ann. Phys 1908, 25, 377–445. [Google Scholar] [CrossRef]
  63. Chelly, M.; Chelly, S.; Zribi, R.; Bouaziz-Ketata, H.; Gdoura, R.; Lavanya, N.; Veerapandi, G.; Sekar, C.; Neri, G. Synthesis of Silver and Gold Nanoparticles from Rumex roseus Plant Extract and Their Application in Electrochemical Sensors. Nanomaterials 2021, 11, 739. [Google Scholar] [CrossRef]
  64. Arshad, H.; Sadaf, S.; Hassan, U. De-novo fabrication of sunlight irradiated silver nanoparticles and their efficacy against E. coli and S. epidermidis. Sci. Rep. 2022, 12, 676. [Google Scholar] [CrossRef] [PubMed]
  65. Ssekatawa, K.; Byarugaba, D.K.; Kato, C.D.; Wampande, E.M.; Ejobi, F.; Nakavuma, J.L.; Maaza, M.; Sackey, J.; Nxumalo, E.; Kirabira, J.B. Green strategy–based synthesis of silver nanoparticles for antibacterial applications. Front. Nanotechnol. 2021, 59, 697303. [Google Scholar] [CrossRef]
  66. Khan, M.; Khan, A.U.; Rafatullah, M.; Alam, M.; Bogdanchikova, N.; Garibo, D. Search for Effective Approaches to Fight Microorganisms Causing High Losses in Agriculture: Application of P. lilacinum Metabolites and Mycosynthesised Silver Nanoparticles. Biomolecules 2022, 12, 174. [Google Scholar] [CrossRef] [PubMed]
  67. Al-Zahrani, S.; Astudillo-Calderón, S.; Pintos, B.; Pérez-Urria, E.; Manzanera, J.A.; Martín, L.; Gomez-Garay, A. Role of synthetic plant extracts on the production of silver-derived nanoparticles. Plants 2021, 10, 1671. [Google Scholar] [CrossRef] [PubMed]
  68. Huq, M.A. Green synthesis of silver nanoparticles using Pseudoduganella eburnea MAHUQ-39 and their antimicrobial mechanisms investigation against drug resistant human pathogens. Int. J. Mol. Sci. 2020, 21, 1510. [Google Scholar] [CrossRef]
  69. Kumar, D.; Kumar, P.; Vikram, K.; Singh, H. Fabrication and characterization of noble crystalline silver nanoparticles from Pimenta dioica leave extract and analysis of chemical constituents for larvicidal applications. Saudi J. Biol. Sci. 2022, 29, 1134–1146. [Google Scholar] [CrossRef]
  70. Oliveira, R.N.; Mancini, M.C.; Oliveira, F.C.S.d.; Passos, T.M.; Quilty, B.; Thiré, R.M.d.S.M.; McGuinness, G.B. FTIR analysis and quantification of phenols and flavonoids of five commercially available plants extracts used in wound healing. Matéria 2016, 21, 767–779. [Google Scholar] [CrossRef]
  71. Nadeem, F.; Fozia, F.; Aslam, M.; Ahmad, I.; Ahmad, S.; Ullah, R.; Almutairi, M.H.; Aleya, L.; Abdel-Daim, M.M. Characterization, Antiplasmodial and Cytotoxic Activities of Green Synthesized Iron Oxide Nanoparticles Using Nephrolepis exaltata Aqueous Extract. Molecules 2022, 27, 4931. [Google Scholar] [CrossRef]
  72. Nagalingam, M.; Kalpana, V.; Panneerselvam, A. Biosynthesis, characterization, and evaluation of bioactivities of leaf extract-mediated biocompatible gold nanoparticles from Alternanthera bettzickiana. Biotechnol. Rep. 2018, 19, e00268. [Google Scholar]
  73. Singh, P.; Mijakovic, I. Green synthesis and antibacterial applications of gold and silver nanoparticles from Ligustrum vulgare berries. Sci. Rep. 2022, 12, 7902. [Google Scholar] [CrossRef] [PubMed]
  74. Elbagory, A.M.; Cupido, C.N.; Meyer, M.; Hussein, A.A. Large scale screening of southern African plant extracts for the green synthesis of gold nanoparticles using microtitre-plate method. Molecules 2016, 21, 1498. [Google Scholar] [CrossRef] [PubMed]
  75. García-Álvarez, R.; Vallet-Regí, M. Hard and soft protein corona of nanomaterials: Analysis and relevance. Nanomaterials 2021, 11, 888. [Google Scholar] [CrossRef]
  76. Yu, Q.; Zhao, L.; Guo, C.; Yan, B.; Su, G. Regulating protein corona formation and dynamic protein exchange by controlling nanoparticle hydrophobicity. Front. Bioeng. Biotechnol. 2020, 8, 210. [Google Scholar] [CrossRef] [PubMed]
  77. Kuppusamy, P.; Ichwan, S.J.; Al-Zikri, P.N.H.; Suriyah, W.H.; Soundharrajan, I.; Govindan, N.; Maniam, G.P.; Yusoff, M.M. In vitro anticancer activity of Au, Ag nanoparticles synthesized using Commelina nudiflora L. aqueous extract against HCT-116 colon cancer cells. Biol. Trace Elem. Res. 2016, 173, 297–305. [Google Scholar] [CrossRef]
  78. Baran, A.; Fırat Baran, M.; Keskin, C.; Hatipoğlu, A.; Yavuz, Ö.; İrtegün Kandemir, S.; Adican, M.T.; Rovshan, K.; Mammadova, A.; Ahmadian, E. Investigation of antimicrobial and cytotoxic properties and specification of silver nanoparticles (AgNPs) Derived from Cicer arietinum L. green leaf extract. Front. Bioeng. Biotechnol. 2022, 10, 263. [Google Scholar] [CrossRef]
  79. Salvioni, L.; Galbiati, E.; Collico, V.; Alessio, G.; Avvakumova, S.; Corsi, F.; Tortora, P.; Prosperi, D.; Colombo, M. Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations. Int. J. Nanomed. 2017, 12, 2517. [Google Scholar] [CrossRef]
  80. Slavin, Y.N.; Asnis, J.; Häfeli, U.O.; Bach, H. Metal nanoparticles: Understanding the mechanisms behind antibacterial activity. J. Nanobiotechnology 2017, 15, 65. [Google Scholar] [CrossRef]
  81. Okkeh, M.; Bloise, N.; Restivo, E.; De Vita, L.; Pallavicini, P.; Visai, L. Gold nanoparticles: Can they be the next magic bullet for multidrug-resistant bacteria? Nanomaterials 2021, 11, 312. [Google Scholar] [CrossRef]
  82. Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 2013, 12, 371–387. [Google Scholar] [CrossRef] [PubMed]
  83. Schmieder, R.; Edwards, R. Insights into antibiotic resistance through metagenomic approaches. Future Microbiol. 2012, 7, 73–89. [Google Scholar] [CrossRef] [PubMed]
  84. Sathishkumar, G.; Gobinath, C.; Karpagam, K.; Hemamalini, V.; Premkumar, K.; Sivaramakrishnan, S. Phyto-synthesis of silver nanoscale particles using Morinda citrifolia L. and its inhibitory activity against human pathogens. Colloids Surf. B: Biointerfaces 2012, 95, 235–240. [Google Scholar] [CrossRef]
  85. Priya Velammal, S.; Devi, T.A.; Amaladhas, T.P. Antioxidant, antimicrobial and cytotoxic activities of silver and gold nanoparticles synthesized using Plumbago zeylanica bark. J. Nanostructure Chem. 2016, 6, 247–260. [Google Scholar] [CrossRef] [Green Version]
Pharmaceutics 15 00529 g001 550
Figure 1. GC-MS chromatograph illustrating the chemical composition of the Haloxylon salicornicum aqueous extract.
Figure 1. GC-MS chromatograph illustrating the chemical composition of the Haloxylon salicornicum aqueous extract.
Pharmaceutics 15 00529 g001
Pharmaceutics 15 00529 g002 550
Figure 2. UV-Vis spectroscopy graphs of H@Ag-NPs and H@Au-NPs synthesized by Haloxylon salicornicum.
Figure 2. UV-Vis spectroscopy graphs of H@Ag-NPs and H@Au-NPs synthesized by Haloxylon salicornicum.
Pharmaceutics 15 00529 g002
Pharmaceutics 15 00529 g003 550
Figure 3. XRD graphs of H@Ag-NPs (A) and H@Au-NPs (B) synthesized using Haloxylon salicornicum.
Figure 3. XRD graphs of H@Ag-NPs (A) and H@Au-NPs (B) synthesized using Haloxylon salicornicum.
Pharmaceutics 15 00529 g003
Pharmaceutics 15 00529 g004 550
Figure 4. FTIR spectra of Haloxylon salicornicum extract (A) and H@Ag-NPs and H@Au-NPs (B).
Figure 4. FTIR spectra of Haloxylon salicornicum extract (A) and H@Ag-NPs and H@Au-NPs (B).
Pharmaceutics 15 00529 g004
Pharmaceutics 15 00529 g005 550
Figure 5. TEM micrographs of H@Ag-NPs (A,B) and H@Au-NPs (C,D) and their frequency distribution (E). Scale bar of (A,B) at 100 nm and (D) at 50 nm.
Figure 5. TEM micrographs of H@Ag-NPs (A,B) and H@Au-NPs (C,D) and their frequency distribution (E). Scale bar of (A,B) at 100 nm and (D) at 50 nm.
Pharmaceutics 15 00529 g005
Pharmaceutics 15 00529 g006 550
Figure 6. Scanning electron microscopy micrographs (A,B) and energy diffraction X-ray (C,D) and map analyses (E,F) of H@Ag-NPs and H@Au-NPs, respectively. Scale bar of (A,B) at 200 nm.
Figure 6. Scanning electron microscopy micrographs (A,B) and energy diffraction X-ray (C,D) and map analyses (E,F) of H@Ag-NPs and H@Au-NPs, respectively. Scale bar of (A,B) at 200 nm.
Pharmaceutics 15 00529 g006
Pharmaceutics 15 00529 g007 550
Figure 7. Dynamic light scattering (A,B) of H@Au-NPs and H@Ag-NPs, respectively, and zeta potential (C,D) graphs of H@Au-NPs and H@Ag-NPs, respectively.
Figure 7. Dynamic light scattering (A,B) of H@Au-NPs and H@Ag-NPs, respectively, and zeta potential (C,D) graphs of H@Au-NPs and H@Ag-NPs, respectively.
Pharmaceutics 15 00529 g007
Pharmaceutics 15 00529 g008 550
Figure 8. Antiproliferative activity of H@Ag-NPs and H@Au-NPs against (A) Sw480 and Sw620, (B) HCT-116 and Caco-2, and (C) HFs and Vero. Data are shown as the mean ± SEM. p-values were calculated using untreated cells as the control. **** p < 0.0001, *** p < 0.0002, ** p < 0.001 and * p < 0.01. ns refers to non-significance.
Figure 8. Antiproliferative activity of H@Ag-NPs and H@Au-NPs against (A) Sw480 and Sw620, (B) HCT-116 and Caco-2, and (C) HFs and Vero. Data are shown as the mean ± SEM. p-values were calculated using untreated cells as the control. **** p < 0.0001, *** p < 0.0002, ** p < 0.001 and * p < 0.01. ns refers to non-significance.
Pharmaceutics 15 00529 g008
Pharmaceutics 15 00529 g009 550
Figure 9. Cell viability % of 5-FU against colon cancer cells Sw480 and Sw620, HCT-116 and Caco-2, and normal cells HFs and Vero cells. Data are shown as the mean ± SEM.
Figure 9. Cell viability % of 5-FU against colon cancer cells Sw480 and Sw620, HCT-116 and Caco-2, and normal cells HFs and Vero cells. Data are shown as the mean ± SEM.
Pharmaceutics 15 00529 g009
Pharmaceutics 15 00529 g010 550
Figure 10. Biocidal inhibitory influence of H@Ag-NPs and H@Au-NPs and H. salicornicum aqueous extract against (A) Staphylococcus aureus, (B) Bacillus cereus, (C) Escherichia coli, and (D) Klebsiella pneumoniae. Written letters on plates refer to (A) H@Ag-NPs, (B) H@Au-NPs, (C) ciprofloxacin, and (D) H. salicornicum aqueous extract.
Figure 10. Biocidal inhibitory influence of H@Ag-NPs and H@Au-NPs and H. salicornicum aqueous extract against (A) Staphylococcus aureus, (B) Bacillus cereus, (C) Escherichia coli, and (D) Klebsiella pneumoniae. Written letters on plates refer to (A) H@Ag-NPs, (B) H@Au-NPs, (C) ciprofloxacin, and (D) H. salicornicum aqueous extract.
Pharmaceutics 15 00529 g010
Pharmaceutics 15 00529 g011 550
Figure 11. The scavenging activity of H@Ag-NPs and H@Ag-NPs and H. salicornicum aqueous extract using FRAP analysis (A) and DPPH (B) assays.
Figure 11. The scavenging activity of H@Ag-NPs and H@Ag-NPs and H. salicornicum aqueous extract using FRAP analysis (A) and DPPH (B) assays.
Pharmaceutics 15 00529 g011
Table
Table 1. The chemical compositions of Haloxylon salicornicum aqueous extracts analyzed by GC-MS.
Table 1. The chemical compositions of Haloxylon salicornicum aqueous extracts analyzed by GC-MS.
No.CompoundRetention TimeArea%Matched FactorMolecular FormulaMolecular WeightChemical Structure
11-Methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-1-vinylcyclohexane), (1R-trans)-10.120.64846C15H24204Pharmaceutics 15 00529 i001
2Cyclohexane, 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-, (1R,2R,4S)-rel-11.461.70880C15H24204Pharmaceutics 15 00529 i002
3Aromandendrene12.05, 12.45,12.87, 13.25, 13.45, 13.67, 14.760.80, 1.38, 0.38, 0.32, 0.70, 1.39, 0.71873, 886, 893, 885, 856, 890, 868C15H24204Pharmaceutics 15 00529 i003
4Beta-longipinene13.160.46828C15H24204Pharmaceutics 15 00529 i004
5 Eremophilene 13.881.65902C15H24204Pharmaceutics 15 00529 i005
6 Alpha-copaene 14.031.30788C15H24204Pharmaceutics 15 00529 i006
7 Gamma-himachalene 14.150.34808C15H24204Pharmaceutics 15 00529 i007
8 o-Menth-8-ene-4-methanol, α,α -dimethyl-1-vinyl-, (1S,2S,4R)-(-)- 14.43, 15.304.45, 3.18899, 909C15H26O222Pharmaceutics 15 00529 i008
9 Beta-cadinene 14.562.55807C15H24204Pharmaceutics 15 00529 i009
10 Beta-guaiene 14.92, 15.870.32, 0.31765, 782C15H24204Pharmaceutics 15 00529 i010
11 Murolan-3,9(11)-diene-10-peroxy 15.030.47 760 C15H24O2236Pharmaceutics 15 00529 i011
12 (-)-Globulol 15.130.48 829 C15H26O 222Pharmaceutics 15 00529 i012
13 Alpha-farnesene 15.630.64 807 C15H24204Pharmaceutics 15 00529 i013
14 10-Epi-gamma-Eudesmol 16.20, 16.68, 17.10, 17.586.38, 6.90, 4.17, 6.24 870, 898, 865, 898 C15H26O222Pharmaceutics 15 00529 i014
15 Guaiol 16.460.31 877 C15H26O 222Pharmaceutics 15 00529 i015
16 Eudesma-4(14),7(11)-diene 17.370.32 786 C15H24204Pharmaceutics 15 00529 i016
17 1-Chlorooctadecane 18.49, 20.561.31, 0.67 768, 755 C18H37Cl 288Pharmaceutics 15 00529 i017
18 Methyl tetradecanoate 19.130.86 694 C15H30O2242Pharmaceutics 15 00529 i018
19 Cadalene 20.120.57 731 C15H18198Pharmaceutics 15 00529 i019
20 2-Acetyl-3-(2-cinnamido)ethyl-7-methoxyindole 20.680.52615C22H22N2O3 362Pharmaceutics 15 00529 i020
21 1,2-15,16-Diepoxyhexadecane 21.350.39717C16H30O2254Pharmaceutics 15 00529 i021
22 Phthalic acid, isobutyl octadecyl ester 22.070.52828C30H50O4474Pharmaceutics 15 00529 i022
23 Ethyl linoleate 22.180.45 714 C20H36O2308Pharmaceutics 15 00529 i023
24 12,15-Octadecadiynoic acid, methyl Ester 22.720.49 713 C19H30O2290Pharmaceutics 15 00529 i024
25 Methyl palmitate 23.2210.50 906 C17H34O2270Pharmaceutics 15 00529 i025
26 n-Hexadecanoic acid 24.593.96 831 C16H32O2256Pharmaceutics 15 00529 i026
27 Cyclopropa[d]naphthalen-3-one, octahydro-2,4a,8,8-tetramethyl-, oxime 25.97, 26.771.87, 0.57 647, 675C15H25NO235Pharmaceutics 15 00529 i027
28 8,11-Octadecadienoic acid, methyl Ester 26.250.83 795 C19H34O2294Pharmaceutics 15 00529 i028
29 9-Octadecenoic acid (Z)-, methyl Ester 26.42, 26.536.81, 3.62 924, 885 C19H36O2296Pharmaceutics 15 00529 i029
30 Methyl stearate 26.95.20 865 C19H38O2298Pharmaceutics 15 00529 i030
31 Methyl 6,8-octadecadiynoate 27.200.86 730 C19H30O2290Pharmaceutics 15 00529 i031
32 Oleic Acid 27.66, 27.993.04, 1.22 812, 774C18H34O2282Pharmaceutics 15 00529 i032
33 1,1-Dichloro-2-(2,2-dichloro-1-methylcyclopropyl)-2-methylcyclopropane 28.834.97 687 C8H10Cl4246Pharmaceutics 15 00529 i033
34 Methyl 14-methyl-eicosanoate 30.250.65 701 C22H44O2340Pharmaceutics 15 00529 i034
35 Dodecanoic acid, 10-methyl-, methyl Ester 33.380.69 771 C14H28O2228Pharmaceutics 15 00529 i035
36 Phthalic acid, 5-methylhex-2-yl heptadecyl ester 33.670.93 805 C32H54O4502Pharmaceutics 15 00529 i036
Table
Table 2. FTIR spectra of Haloxylon salicornicum extract, H@Ag-NPs and H@Au-NPs and its corresponding functional groups.
Table 2. FTIR spectra of Haloxylon salicornicum extract, H@Ag-NPs and H@Au-NPs and its corresponding functional groups.
FTIR Spectra (cm−1)Functional Gtoups of Haloxylon salicornicumFTIR Spectra (cm−1)Functional Gtoups of H@Ag-NPsFTIR Spectra (cm−1)Functional Gtoups of H@Au-NPs
3368.04O-H 3424.7O-H 3424.7O-H
1634.5N-H 2928.8C-H 2928.8C-H
1467.1C-H 2861.8C-H 2861.8C-H
1409.01O-H1634.0C=C1747.4C=O
1330.7C-N1510.3N-O 1634.0C=C
1251.4C-O1386.5C-H 1465.9C-H
1093.8C-O 1240.2C-N 1231.0C-N
907.4C=C 1059.7C-O 1173.2C-O
829.9C-Cl 587.6C-Cl1059.7C-O
721.2C=C 582.0C-Cl
609.7C-Cl
500.0C-I
Table
Table 3. Elemental compositions of both H@Ag-NPs and H@Au-NPs analyzed by energy diffraction X-ray.
Table 3. Elemental compositions of both H@Ag-NPs and H@Au-NPs analyzed by energy diffraction X-ray.
H@Ag-NPsH@Au-NPs
ElementsLineMass%Atom%ElementsLineMass%Atom%
CK2.55 ± 0.0116.44 ± 0.06CK3.97 ± 0.0235.88 ± 0.14
OK0.58 ± 0.012.80 ± 0.06AlK0.21 ± 0.010.85 ± 0.04
AlK0.14 ± 0.010.41± 0.02CuK5.54 ± 0.089.45 ± 0.13
ClK7.08 ± 0.0215.46 ± 0.05ZnK3.73 ± 0.096.18 ± 0.15
CuK1.04 ± 0.041.26 ± 0.05AuM86.55 ± 0.14 47.64 ± 0.08
AgL88.61 ± 0.1063.62 ± 0.07
Total 100100Total 100100
Table
Table 4. Minimum inhibition and bactericidal concentrations (MIC and MBC) of H@Ag-NPs and H@Ag-NPs and H. salicornicum aqueous extract against Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Klebsiella pneumoniae.
Table 4. Minimum inhibition and bactericidal concentrations (MIC and MBC) of H@Ag-NPs and H@Ag-NPs and H. salicornicum aqueous extract against Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Klebsiella pneumoniae.
BacteriaH@Ag-NPs (µg/mL)H@Au-NPs (µg/mL)H. salicornicum (µg/mL)
MICMBCMICMBCMICMBC
S.aureus1.953.9>500>500>500>500
B. cereus3.907.8>500>500>500>500
K. pneumoniae3.907.81>500>500>500>500
E. coli7.815.6>500>500>500>500
Table
Table 5. Inhibition zone diameter (mm) of H@Ag-NPs and H@Ag-NPs and H. salicornicum aqueous extract against Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Klebsiella pneumoniae.
Table 5. Inhibition zone diameter (mm) of H@Ag-NPs and H@Ag-NPs and H. salicornicum aqueous extract against Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Klebsiella pneumoniae.
StrainsCiprofloxacin H@Ag-NPsH@Au-NPsH. salicornicum
S.aureus30.0 ± 0.217.0 ± 0.10.0 ± 0.012.0 ± 0.1
B. cereus32.0 ± 0.313.4 ± 0.20.0 ± 0.011.0 ± 0.2
E. coli30.0 ± 0.213.0 ± 0.30.0 ± 0.09.8 ± 0.3
K. pneumoniae32.0 ± 0.213.3 ± 0.40.0 ± 0.09.9 ± 0.6
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hamida, R.S.; Ali, M.A.; Alfassam, H.E.; Momenah, M.A.; Alkhateeb, M.A.; Bin-Meferij, M.M. One-Step Phytofabrication Method of Silver and Gold Nanoparticles Using Haloxylon salicornicum for Anticancer, Antimicrobial, and Antioxidant Activities. Pharmaceutics 2023, 15, 529. https://doi.org/10.3390/pharmaceutics15020529

AMA Style

Hamida RS, Ali MA, Alfassam HE, Momenah MA, Alkhateeb MA, Bin-Meferij MM. One-Step Phytofabrication Method of Silver and Gold Nanoparticles Using Haloxylon salicornicum for Anticancer, Antimicrobial, and Antioxidant Activities. Pharmaceutics. 2023; 15(2):529. https://doi.org/10.3390/pharmaceutics15020529

Chicago/Turabian Style

Hamida, Reham Samir, Mohamed Abdelaal Ali, Haifa Essa Alfassam, Maha Abdullah Momenah, Mariam Abdulaziz Alkhateeb, and Mashael Mohammed Bin-Meferij. 2023. "One-Step Phytofabrication Method of Silver and Gold Nanoparticles Using Haloxylon salicornicum for Anticancer, Antimicrobial, and Antioxidant Activities" Pharmaceutics 15, no. 2: 529. https://doi.org/10.3390/pharmaceutics15020529

APA Style

Hamida, R. S., Ali, M. A., Alfassam, H. E., Momenah, M. A., Alkhateeb, M. A., & Bin-Meferij, M. M. (2023). One-Step Phytofabrication Method of Silver and Gold Nanoparticles Using Haloxylon salicornicum for Anticancer, Antimicrobial, and Antioxidant Activities. Pharmaceutics, 15(2), 529. https://doi.org/10.3390/pharmaceutics15020529

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop